LDS/Medical Tests/HDL Cholesterol ( High Density Lipoprotein)

HDL Cholesterol ( High Density Lipoprotein)

High density lipoprotein or HDL is sometimes called the “good cholesterol” because of its ability to remove cholesterol from artheromas within arteries and transport it back to the liver for excretion or reutilization. It is the largest of the five major groups of lipoproteins. In a normal healthy individual, approximately 30% of cholesterol is carried by HDL. Recent studies suggest that HDL plays a major role in transporting free cholesterol from peripheral tissues to the liver. The cholesterol is transformed to bile acids which are excreted into the intestine via the biliary tract. The transport diminishes the risk of deposits on the arterial wall. It has clinical importance because there is an inverse correlation between serum HDL cholesterol and risk of atherosclerotic disease. HDL cholesterol is higher in women than in men. The elevated concentrations are protective against coronary heart disease while decreased concentrations increase risk (particularly with elevated triglycerides). 

  • Diagnosis of familial hyperalphalipoproteinemia and hypoalphalipoproteinemia
  • Evaluate the risk for of coronary heart disease
  • Evaluation of atherosclerosis (arteriosclerotic vascular disease)
  • Diagnosis of familial hypercholesterolemia
  • As an aid in diagnosis of diabetes mellitus, nephrotic syndrome and liver disease with biliary obstruction
  • Monitoring drug treatment therapy
  • Diagnosis of Fish-eye disease
  • Diagnosis of Tangier disease
  • A-1 Milano disease
  • Lecithin cholesterol acyltransferase deficiency

Increased in:

  • Insulin-treated diabetes
  • Oral contraceptives
  • Ascorbic Acid
  • Alcohol intake

Decreased in:

  • Coronary heart disease
  • Acquired immunodeficiency syndrome
  • Diabetes (untreated)
  • Acute or chronic liver disease

Reference Ranges:

<40 mg/dL (1.036 mmol/L)

Females:             No risk                Moderate risk             High risk

                        >65 mg/dL            45-65 mg/dL              <45 mg/dL

                        >1.68 mmol/L       1.15-1.68 mmol/L      <1.15 mmol/L

 

Males:             >55 mg/dL             35-55 mg/dL              <40 mg/dL

                       >1.45 mmol/L       0.90-1.45 mmol/L      <1.03 mmol/L

 

Enzymatic.

Serum (SST) or plasma (purple top tube or EDTA).

Stability 

  • Ambient: 3-5 days 
  • Refrigerated: 5-7 days 
  • Frozen: 90 days
Lipid Panel, Lipoprotein Electrophoresis, Homocysteine, BNP, Lipid profile, Apolipoprotein A-I, Apolipoprotein B-100, C-reactive protein (CRP), VLDL-C (very low density lipoprotein cholesterol), NMR Lipo profile, Liver panel.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Curr Opin Cardiol. 2006 Jul;21(4):400-4. [PMID: 16755211]
  • JAMA. 1999 Dec 1;282(21):2051-7. [PMID: 10591388]
  • Pharmacotherapy. 2003 Sep;23(9 Pt 2):26S-33S. [PMID: 14524636]
  • Howanitz JH and Howanitz PJ. Laboratory Medicine Test Selection and Interpretation. New York, NY, Churchill Livingstone (1991). Pages 46, 47, 270.